Compare Marsh & McLennan Companies, Inc. (MRSH) vs Verisign, Inc. (VRSN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marsh & McLennan Companies, Inc. vs Verisign, Inc. — how do they compare? Marsh & McLennan Companies, Inc. trades at $176.89 (market cap $84.39B), while Verisign, Inc. trades at $287 (market cap $25.94B). The key difference: Marsh & McLennan Companies, Inc. is far larger — about 3.3× Verisign, Inc.'s market cap, and Marsh & McLennan Companies, Inc. pays the higher dividend (2.24%). Which is the better fit depends on your goals.
| MRSH | VRSN | |
|---|---|---|
Market Cap | $84.39B | $25.94B |
Sector | Financials | Technology |
52-Week High | $207.02 | $310.00 |
52-Week Low | $157.32 | $211.49 |
Enterprise Value | $105.07B | $27.25B |
Dividend Yield | 2.24% | 1.13% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Marsh & McLennan (MRSH) trades at $180.52, down 2.81% on the day, with a bullish technical signal despite recent weakness. The company shows solid fundamentals with revenue growth to $26.98B in 2025 and consistent earnings beats. Analyst consensus is a Buy with a $208.63 price target, though sentiment is mixed with 66.7% Hold ratings. Recent news highlights expansion in cyber protection services and insights on healthcare cost trends.
The outlook remains positive given strong profitability and strategic initiatives, but risks include economic sensitivity and competitive pressures. The stock offers upside to the consensus target, supported by institutional interest and stable cash flows, though high valuation multiples warrant caution amid market volatility.
VeriSign (VRSN) trades at $282.20, down 3.38% on the day, with a bearish technical signal despite strong institutional buying interest. The company maintains exceptional profitability with 49.77% net margins and consistent revenue growth, though recent earnings have been mixed with two misses in the last four quarters. A major antitrust lawsuit filed in September 2026 poses significant regulatory risk, while analyst consensus remains bullish with a $328.50 price target representing 16% upside potential.
The stock presents a compelling value proposition given its strong cash flow generation and dominant market position in domain registry services, but faces headwinds from legal challenges and competitive pressures. Current valuation at 30.64 P/E appears reasonable for the quality of earnings, though the negative shareholder equity position warrants monitoring of debt levels. Upside potential exists if the company successfully navigates regulatory challenges and maintains its pricing power.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Marsh & McLennan Companies, Inc.
Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).
Read more on MRSH →About Verisign, Inc.
Verisign is the sole authorized registry for several generic top-level domains, including the widely utilized .com and .net top-level domains. The company operates critical Internet infrastructure to support the domain name system, including operating two of the world's 13 root servers that are used to route Internet traffic. In 2018, the firm sold off its Security Services business, signalling a renewed focus on the core registry business.
Read more on VRSN →
